Truist Financial’s CorMedix CRMD Stock Holding History

Truist Financial’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Buy	22,146 +2,534	+13%	+$20K	﹤0.01%	2815
2026 Q1	$133K	Buy	19,612 +2,773	+16%	+$20.5K	﹤0.01%	2693
2025 Q4	$196K	Buy	16,839 +4,839	+40%	+$53.5K	﹤0.01%	2614
2025 Q3	$140K	Hold	12,000	–	–	﹤0.01%	2599
2025 Q2	$146K	Hold	12,000	–	–	﹤0.01%	2461
2025 Q1	$130K	Hold	12,000	–	–	﹤0.01%	2420
2024 Q4	$97.2K	Hold	12,000	–	–	﹤0.01%	2468
2024 Q3	$97K	Hold	12,000	–	–	﹤0.01%	2421
2024 Q2	$52K	Hold	12,000	–	–	﹤0.01%	2611
2024 Q1	$50.9K	Hold	12,000	–	–	﹤0.01%	2582
2023 Q4	$45.1K	Hold	12,000	–	–	﹤0.01%	2597
2023 Q3	$44.4K	Buy	+12,000	New	+$47.7K	﹤0.01%	2553

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Truist Financial's CRMD Position: Q2 2026 in Review

Truist Financial increased its CorMedix (CRMD) stake by 13% in Q2 2026, buying an estimated $20K and bringing the position to 22,146 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #2815.

Truist Financial first reported a position in CRMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $196K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Truist Financial held 22,146 shares of CorMedix worth $174K as of Q2 2026.
Truist Financial bought 2,534 CorMedix shares in Q2 2026, an estimated $20K.
CorMedix made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2815 holding.
Truist Financial first reported a position in CorMedix in Q3 2023 and has held it in 12 quarters since.
Truist Financial's CorMedix position peaked at $196K in Q4 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.